Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000144

Chairperson & CEO sold 9,500 shares at an average $496.06 ($4,712,580)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-17 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-17 Sale : show line 2 in the form 10b5-1 −599 $493.22 $295,436 333,344 I
2026-09-17 Sale : show line 3 in the form 10b5-1 −1,750 $494.34 $865,096 331,594 I
2026-09-17 Sale : show line 4 in the form 10b5-1 −1,905 $495.11 $943,183 329,689 I
2026-09-17 Sale : show line 5 in the form 10b5-1 −2,182 $496.21 $1,082,721 327,507 I
2026-09-17 Sale : show line 6 in the form 10b5-1 −1,953 $497.17 $970,978 325,554 I
2026-09-17 Sale : show line 7 in the form 10b5-1 −151 $497.79 $75,166 325,403 I
2026-09-17 Sale : show line 8 in the form 10b5-1 −332 $499.10 $165,701 325,071 I
2026-09-17 Sale : show line 9 in the form 10b5-1 −468 $500.09 $234,043 324,603 I
2026-09-17 Sale : show line 10 in the form 10b5-1 −160 $501.60 $80,256 324,443 I
Open-market sales · 9,500 sh · avg $496.06 · $4,712,580

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-17 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option −9,500 413,910 I
Loading xslF345X06/primarydocument.xml…